查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1470599

白蛋白市場：按來源、類型、應用程式和最終用戶 - 2024-2030 年全球預測

Albumin Market by Source (Animal Sources, Plant Sources), Type (Non-Recombinant, Recombinant), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年白蛋白市場規模為65.3億美元，預計2024年將達69.4億美元，2030年將達102.3億美元，複合年成長率為6.61%。

白蛋白是一種複雜且用途廣泛的蛋白質，約佔人體血漿總蛋白質的 50% 至 60%。它主要在肝臟中合成，在維持滲透壓、結合和運輸各種分子以及作為抗氧化劑等生理功能中發揮重要作用。白蛋白的重要性在於其對整體健康和福祉的多維貢獻，使其成為評估個別疾病風險和臨床狀態的重要生物標記。由於燒燙傷的治療和肝病的日益流行，患者需要定期供應 HSA 以維持正常的健康功能，白蛋白在臨床實踐中的使用正在增加，全球範圍內白蛋白的使用正在加速。然而，源自混合人類血漿的 HSA 產品污染和傳染性病原體傳播相關的風險影響了白蛋白的使用。每個地區嚴格的產品認證監管指南也會影響白蛋白的商業化。市場開拓正在投資研發，探索創新的生產方法，例如基於植物的表達系統和微生物發酵工藝，可以以更低的成本生產高品質的白蛋白產品。生物技術的進步使得透過基因工程技術生產重組人體血清蛋白（rHA）成為可能，這正在創造新的機會。

主要市場統計
基準年[2023] 65.3億美元
預測年份 [2024] 69.4億美元
預測年份 [2030] 102.3億美元
複合年成長率（%） 6.61%

由於特定治療目的的永續性，消費者轉向植物來源白蛋白。

白蛋白是血液中的重要蛋白質，在維持體液平衡和運輸荷爾蒙、脂肪酸和藥物方面發揮重要作用。白蛋白有兩種主要來源：動物來源和植物來源。動物源性白蛋白可從牛血清 (BSA)、人類血漿 (HSA) 和 OV 白蛋白中取得。牛血清白蛋白 (BSA) 是診斷劑、疫苗和細胞培養基等多種應用的重要成分。 BSA 廣泛用於診斷和研究，因為它價格實惠且容易獲得。人類血清白蛋白 (HSA) 由於其與人類的高度生物相容性，在某些臨床情況下是首選，例如藥物輸送系統和擴容療法。 HSA 用於醫療緊急情況，例如燒燙傷治療和心肺體外迴圈手術。近年來，植物來源替代品因其減少的環境影響和潛在的過敏原風險而成為一種永續的選擇。植物來源白蛋白（包括米蛋白質和大豆蛋白）作為動物源性白蛋白的替代品在食品和飲料和飲料、藥品和化妝品等應用中越來越受歡迎。相較之下，動物源性白蛋白已建立醫學應用，儘管有疾病傳播的風險。相較之下，植物來源白蛋白具有永續性，污染風險最小，但可能不適合特定的治療目的。然而，消費者在動物性和植物性白蛋白之間進行選擇的趨勢取決於多種因素，例如預期用途、純度要求、永續性問題以及與動物性蛋白質相關的潛在風險。

為了推廣重組DNA技術，我們重點研究並開發了重組白蛋白作為合成蛋白。

非重組白蛋白是天然衍生的，主要來自人類和牛血清。由於其穩定蛋白質和酵素的能力，它被廣泛應用於藥物製劑、診斷劑、細胞培養基和醫療設備。基於需求的對非重組白蛋白的偏好源於其作為血液分離過程的產物而大量可用。重組白蛋白是使用基因工程表現系統（例如酵母或哺乳動物細胞）生產的。與非重組白蛋白相比，不存在病原體污染的風險，並且可以實現更穩定且永續的供應。重組白蛋白主要用於藥物傳遞系統、疫苗、細胞治療及再生醫學。重組白蛋白是優選的，因為它是安全的，因為它不含有可以傳播感染疾病的人類或動物來源的成分。

越來越關注應用疫苗生產和藥物傳輸應用

白蛋白因其優異的保水性能而被廣泛用作化妝品原料，可增強皮膚的保濕性和彈性。在生物技術產業中，白蛋白是支持細胞生長和增殖的培養基的重要組成部分。白蛋白在藥物傳遞的應用利用其結合不同分子同時在各種條件下保持穩定的能力。白蛋白由於其乳化和發泡等功能而被用作多種產品的食品成分。基於白蛋白的療法已用於治療低白蛋白血症和燒燙傷等疾病。此外，疫苗製造商使用白蛋白作為穩定劑和防腐劑，以增加疫苗在儲存和運輸過程中的穩定性。

最終用戶：醫院和血庫白蛋白的廣泛最終用戶

白蛋白的主要最終用戶分為醫院和診所、製藥和生技公司、學術研究機構和血庫等第一級產業。這些設施將白蛋白產品用於多種目的，包括藥物配製、診斷、疫苗生產、臨床營養支持、細胞培養生長培養基補充和血液容量擴充。在醫院和診所，白蛋白經常用於治療因嚴重或受傷引起的低白蛋白血症（一種以血液中白蛋白水平較低為特徵的疾病）患者。它也用於在手術和涉及出血的創傷期間復甦體液。近年來，白蛋白作為腸外營養配方中的成分也受到歡迎，為口服攝取困難的患者提供必需的蛋白質。此外，它在血庫中用作血漿擴張劑，以增加接受輸血或因外傷、手術或其他情況而嚴重出血的患者的血液容量。白蛋白溶液有助於在這種關鍵條件下維持滲透壓、穩定血液動力學參數並改善整體循環功能。

區域洞察

美洲白蛋白市場是由製藥公司的投資推動的，這些公司正在大力投資研究和技術以開發先進的白蛋白配方。美國食品藥物管理局（FDA）等監管機構實施了嚴格的品管，以確保白蛋白的安全標準。近年來，FDA 也批准了某些白蛋白產品。在美國和加拿大，正在研究重組 HSA 生產等技術進步，以減少對人類血漿捐贈白蛋白供應的依賴。由於新興國家醫療保健支出的增加和醫療基礎設施的改善，亞洲白蛋白市場正在迅速擴大，這些國家需要血漿衍生產品用於肝病治療、手術和加護治療支持等治療目的。歐洲擁有成熟的消費基礎和強大的製造能力，有潛力為全球白蛋白市場做出貢獻。白蛋白在歐洲的使用主要集中在重症加護應用，例如敗血症管理、容量替代療法和治療性血漿置換手術。歐洲藥品管理局 (EMA) 負責監管歐盟 (EU) 內白蛋白的生產和分銷。

FPNV定位矩陣

FPNV定位矩陣對於評估白蛋白市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對白蛋白市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.白蛋白市場規模及預測為何？

2.白蛋白市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.白蛋白市場的技術趨勢和法規結構是什麼？

4.白蛋白市場主要廠商的市場佔有率是多少？

5.進入白蛋白市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 使用白蛋白作為慢性病發生率和術後手術部位感染的預測因子
      • 白蛋白作為食品和化妝品原料的使用正在迅速增加。
    • 抑制因素
      • 白蛋白可引起感染
    • 機會
      • 白蛋白奈米顆粒正在進行的研究活動
      • 白蛋白生產和精製方法的進展
    • 任務
      • 白蛋白生產和品管相關的嚴格規定
  • 市場區隔分析
    • 資料來源：由於某些治療目的的永續性增強，消費者正在轉向植物來源白蛋白。
    • 類型：加強重組白蛋白作為合成蛋白的研發，推動重組DNA技術
    • 應用：越來越關注疫苗製造和藥物傳輸應用
    • 最終用戶：醫院和血庫白蛋白的廣泛最終用戶
  • 市場趨勢分析
    • 美洲各地的強勁投資補充了醫療技術的進步
    • 擴大生產，並制定安全法規來監控亞太地區的白蛋白產品
    • 歐洲、中東和非洲地區的重大研究活動和政府法規結構。
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章白蛋白市場：依來源分類

  • 動物起源
  • 植物來源

第7章白蛋白市場：依類型

  • 非重組
  • 重組

第8章白蛋白市場：依應用分類

  • 化妝品原料
  • 文化媒體
  • 藥物輸送
  • 食品添加物
  • 治療性的
  • 疫苗成分

第 9 章 白蛋白市場：依最終使用者分類

  • 製藥/生物技術
  • 調查機構

第10章美洲白蛋白市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區白蛋白市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲白蛋白市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Grifols 完成補償肝硬化患者長期白蛋白（人類用白蛋白注射液）治療的 3 期試驗入組
    • Kedrion 的全球投資組合擴展到中國並開始提供人力資源
    • GC Biopharma 在巴西簽署 9,000 萬美元血液製品合約
    • Albumedix 與 Cell and Gene Therapy Catapult 簽署合作協議
    • Albumedix 和 Valneva 擴大合作範圍，納入新核准的去活化 COVID-19 疫苗
    • American Regent 推出用於注射混懸液的紫杉醇蛋白結合顆粒（白蛋白結合）
    • SK Plasma 將耗資 2.5 億美元在印尼建造血液製品工廠
    • Grifols 在擴建的都柏林工廠開設新的白蛋白工廠
    • Sartorius 收購 Albumedics：Albumin，一家先進重組治療方法領域的公司
    • Tyvan Biologics Group 獲得 3 億美元融資

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-436901065945

[192 Pages Report] The Albumin Market size was estimated at USD 6.53 billion in 2023 and expected to reach USD 6.94 billion in 2024, at a CAGR 6.61% to reach USD 10.23 billion by 2030.

Albumin is a complex and versatile protein that constitutes approximately 50%-60% of the total protein content in human blood plasma. It is synthesized predominantly by the liver and plays an essential role in physiological functions, such as maintaining osmotic pressure, binding and transporting various molecules, and acting as an antioxidant. Albumin's importance lies in its multifaceted contributions to overall health and well-being, making it a significant biomarker for assessing an individual's disease risk and clinical status. The growing usage of albumin in clinical settings for the treatment of burns and the rising prevalence of liver diseases where patients require a regular supply of HSA to maintain proper health functions has accelerated the use of albumin worldwide. However, risks associated with contamination and transmission of infectious agents in HSA products sourced from pooled human plasma donations impact albumin usage. Stringent regulatory guidelines for product approvals in different regions also affect the commercialization of albumin. Market players are investing in research and development initiatives that explore innovative production methods, such as plant-based expression systems or microbial fermentation processes capable of yielding high-quality albumin products at lower costs. New opportunities are emerging with the evolution of biotechnological advancements that enable the production of recombinant human albumins (rHA) through genetic engineering techniques.

KEY MARKET STATISTICS
Base Year [2023] USD 6.53 billion
Estimated Year [2024] USD 6.94 billion
Forecast Year [2030] USD 10.23 billion
CAGR (%) 6.61%

Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.

Albumin, an important protein in the blood, plays essential role in maintaining fluid balance and transporting hormones, fatty acids, and drugs. The two primary albumin sources are animal-based and plant-based. Animal-derived albumin is obtained from bovine serum (BSA), human plasma (HSA), and ovalbumin. Bovine serum albumin (BSA) is a vital ingredient in various applications, such as diagnostic reagents, vaccines, and cell culture media. BSA is widely utilized in diagnostics and research due to its affordability and accessibility. Human serum albumin (HSA) is preferred for certain clinical situations, such as drug delivery systems or volume expansion therapies, due to its biocompatibility with humans. HSA is used in medical emergencies such as burns treatment and cardiopulmonary bypass surgery. In recent years, plant-based alternatives have emerged as a sustainable option for albumin production due to their reduced environmental impact and potential allergen risks. Plant-derived albumins, including rice and soy protein, are gaining popularity as alternatives to animal-derived counterparts for applications in food & beverage production, pharmaceuticals, and cosmetics. Comparatively, animal-derived albumins have established medical applications, although they pose a risk of disease transmission. In contrast, plant-based albumins offer sustainability with minimal contamination risk but may lack compatibility for specific therapeutic purposes. However, consumer trends to preferences to choose products between animal or plant-based albumins depend on factors such as application purpose, purity requirements, sustainability concerns, and potential risks associated with animal proteins.

Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology

Non-recombinant albumin is derived from natural sources, primarily human and bovine serum. It is widely used in pharmaceutical formulations, diagnostics, cell culture media, and medical devices due to its stabilizing properties for proteins and enzymes. The need-based preference for non-recombinant albumin arises from its availability in large quantities as a byproduct of blood fractionation processes. Recombinant albumin is produced using genetically engineered expression systems such as yeast and mammalian cells. It eliminates the risk of contamination with pathogens and offers a more consistent and sustainable supply compared to non-recombinant albumin. Recombinant albumin is mainly used in drug delivery systems, vaccines, cell therapy applications, and regenerative medicine. The preference for recombinant albumin is driven by its safety profile, as it is free from human or animal-derived components which may carry potential risks of transmitting infectious agents.

Application: Rising focus on vaccine manufacturing and drug delivery applications

Albumin is widely used as a cosmetic ingredient due to its excellent water-binding properties, enhancing skin hydration and elasticity. In the biotechnology industry, albumin serves as an essential component of culture media to support cell growth and proliferation. Albumin's drug delivery application capitalizes on its ability to bind various molecules while maintaining stability in different conditions. Albumin is employed in various products as a food ingredient due to its functional properties, such as emulsification and foaming. Albumin-based therapeutics are employed in treatments for conditions such as hypoalbuminemia and burns. Moreover, vaccine manufacturers use albumins as stabilizers or preservatives to enhance vaccine stability during storage and transportation.

End-User: Extensive end-users of the albumin in hospitals and blood banks

The major end-users of albumin can be categorized into primary sectors including, hospitals & clinics, pharmaceutical & biotechnology companies, academic research institutes, and blood banks. These establishments utilize albumin products for various purposes such as drug formulation, diagnostics, vaccine manufacturing, clinical nutrition support, cell culture growth media supplementation, and blood volume expansion. In hospitals & clinics Albumin is often employed to treat patients suffering from hypoalbuminemia - a condition characterized by low levels of albumin in the blood - caused by critical illness or injury. Additionally, it is utilized for fluid resuscitation during surgeries or trauma cases where blood loss has occurred. In recent years, albumin has also gained popularity as a component of parenteral nutrition formulas providing essential proteins needed for patients who are unable to consume food orally. Moreover, blood banks utilize it as a plasma expander to increase blood volume in patients undergoing blood transfusion or those with severe blood loss due to trauma, surgery, or other conditions. Albumin solutions can help maintain osmotic pressure, stabilize hemodynamic parameters, and improve overall circulatory function during such critical situations.

Regional Insights

The Americas albumin market is advancing, driven by investments by pharmaceutical companies investing heavily in research and technology to develop advanced albumin formulations. Regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. enforce strict quality control measures to assure safety standards of albumin. The FDA has also given approval for certain albumin products in recent years. Technological advancements such as recombinant HSA production are being researched across the U.S. and Canada to potentially reduce dependency on human plasma donations for albumin supply. The Asian albumin market is experiencing rapid expansion fueled by increasing healthcare expenditure and improving medical infrastructure in emerging countries demanding plasma-derived products for therapeutic purposes, including liver disease treatment, surgeries, and intensive care support. Europe is a potential contributor to the global albumin market, with an established consumption base and robust manufacturing capabilities. The use of albumin in Europe is primarily focused on critical care applications such as sepsis management, volume replacement therapies, and therapeutic plasma exchange procedures. The European Medicines Agency (EMA) regulates the production and distribution of albumin within the European Union (EU).

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Albumin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Albumin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Albumin Market, highlighting leading vendors and their innovative profiles. These include Aadi Bioscience, Inc., Agilent Technologies, Inc., Akron Biotech, Atlantis Bioscience Pte Ltd., Avantor Inc., Baxter International Inc., Becton, Dickinson and Company, Bio Products Laboratory Ltd., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenix Inc. Pvt. Ltd., Biophyll GmbH, Biorbyt Ltd., Biowest SAS, Boston BioProducts Inc., Bristol-Myers Squibb Company, CENTURION PHARMA Ilac Sanayi ve Ticaret A.S., China Biologic Products Holdings, Inc. by Taibang Biologic Group, CSL Limited, Dem Ilac, F. Hoffmann-La Roche AG, GC Biopharma Corp., Glentham Life Sciences Limited, Grifols SA, InVitria, InVitroCare Inc., Kedrion S.p.A, Kraeber & Co. GmbH, Lazuline Biotech Private Limited, LGC Science Group Holdings Limited, Merck KGaA, Midas Pharma GmbH, Octapharma AG, Promega Corporation, Prospec-Tany Technogene Ltd., Rockland Immunochemicals Inc., Rocky Mountain Biologicals, LLC, Sartorius AG, Serion GmbH, SK Plasma, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., Ventria Bioscience Inc., and VitroScient.

Market Segmentation & Coverage

This research report categorizes the Albumin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source
    • Animal Sources
      • Bovine Serum Albumin
      • Human Serum Albumin
      • Ovalbumin
    • Plant Sources
  • Type
    • Non-Recombinant
    • Recombinant
  • Application
    • Cosmetic Ingredient
    • Culture Media
    • Drug Delivery
    • Food Ingredient
    • Therapeutic
    • Vaccine Ingredient
  • End User
    • Pharmaceutical & Biotechnology
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Albumin Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Albumin Market?

3. What are the technology trends and regulatory frameworks in the Albumin Market?

4. What is the market share of the leading vendors in the Albumin Market?

5. Which modes and strategic moves are suitable for entering the Albumin Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Incidence of chronic diseases and use of albumin as a predictor of postoperative surgical site infections
      • 5.1.1.2. Surging utilization of albumin as a food and cosmetic ingredient
    • 5.1.2. Restraints
      • 5.1.2.1. Potential of albumin to cause transmission of infections
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research activities regarding albumin nanoparticles
      • 5.1.3.2. Advancements in albumin production and purification methods
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with albumin manufacturing and quality control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.
    • 5.2.2. Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology
    • 5.2.3. Application: Rising focus on vaccine manufacturing and drug delivery applications
    • 5.2.4. End-User: Extensive end-users of the albumin in hospitals and blood banks
  • 5.3. Market Trend Analysis
    • 5.3.1. Medical technology advancements supplemented with robust investment across the Americas
    • 5.3.2. Expanding production coupled with availability of safety regulations to monitor albumin products in APAC region
    • 5.3.3. Significant research activities and government regulatory framework in the EMEA region.
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Albumin Market, by Source

  • 6.1. Introduction
  • 6.2. Animal Sources
  • 6.3. Plant Sources

7. Albumin Market, by Type

  • 7.1. Introduction
  • 7.2. Non-Recombinant
  • 7.3. Recombinant

8. Albumin Market, by Application

  • 8.1. Introduction
  • 8.2. Cosmetic Ingredient
  • 8.3. Culture Media
  • 8.4. Drug Delivery
  • 8.5. Food Ingredient
  • 8.6. Therapeutic
  • 8.7. Vaccine Ingredient

9. Albumin Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology
  • 9.3. Research Institutes

10. Americas Albumin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Albumin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Albumin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Grifols Completes Enrollment In Phase 3 Study Of Long-Term Albutein (Albumin-Human Injection) Therapy For Patients With Decompensated Cirrhosis
    • 13.3.2. Kedrion's Global Portfolio Expands To China To Supply Human Albumin
    • 13.3.3. GC Biopharma inks USD 90mn deal for blood products in Brazil
    • 13.3.4. Albumedix Enters into Collaboration Agreement with Cell and Gene Therapy Catapult
    • 13.3.5. Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine
    • 13.3.6. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
    • 13.3.7. SK Plasma to build USD 250m blood products plant in Indonesia
    • 13.3.8. Grifols Inaugurates New Albumin Plant At its Expanding Dublin Site
    • 13.3.9. Sartorius acquires Albumedix: A player in advanced therapies based on recombinant albumin
    • 13.3.10. Taibang Biologic Group Secures Equity Raising of USD 300 Million

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ALBUMIN MARKET RESEARCH PROCESS
  • FIGURE 2. ALBUMIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALBUMIN MARKET DYNAMICS
  • FIGURE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ALBUMIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. ALBUMIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALBUMIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ALBUMIN MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 375. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 376. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 377. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 378. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 383. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 384. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 385. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 386. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 387. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 388. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 391. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 392. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 393. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 394. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 395. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 396. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 397. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 398. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 399. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 400. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 401. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 402. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 403. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 404. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 405. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 406. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 407. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2023 (USD MILLION)
  • TABLE 408. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2024-2030 (USD MILLION)
  • TABLE 409. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 410. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 411. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 412. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)

TA